Live Quote · NASDAQGMABHealthcare· Biotechnology

Genmab A/S

$50.60▼ 1.46%($-0.75)
MKT CAP $31.20BNEXT EARNINGS Feb 16, 2027
50%
Bullish
TickerSpark Score
67/100
▌ Solid
52
Valuation
85
Profitability
10
Growth
88
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GMAB research report →

Analyst Price Target
$50.83+0.5% vs. today

Range $40 – $70

Analyst RatingBuy
14 Buy3 Hold1 Sell

Price Chart

+69.11% · this period
$57.29$40.57$23.85Nov 20May 26Nov 20
52-Week Range74% of range
Low
$23.62
Current
$50.60
High
$59.97

AI analysis · Last refreshed November 19, 2026 · Live quote · Not investment advice